12 published guides. Coverage is limited to the combinations listed.
Edible grapefruit flesh from Citrus paradisi with oral systemic cyclosporine. Whole-fruit avoidance comes from the exact medicine’s label; juice trial results provide supporting context and are not described as flesh experiments.
Read the interaction guide →Oral quercetin supplements with systemic oral cyclosporine. This assessment does not assign the same effect to ordinary dietary amounts, rutin, quercetin glycosides or enhanced-bioavailability formulations. Animal cyclosporine preparations are identified separately.
Read the interaction guide →Oral potassium chloride supplements, replacement products and potassium-chloride salt substitutes with systemic oral cyclosporine. Potassium from this salt is the relevant exposure. Concentrated intravenous potassium is outside this article’s administration advice.
Read the interaction guide →Applies to systemic cyclosporine, with much of the direct evidence from oral treatment in transplant recipients; it does not apply to cyclosporine eye drops.
Read the interaction guide →Oral tocophersolan, d-alpha-tocopheryl polyethylene glycol 1000 succinate or TPGS, with systemic oral cyclosporine. Historical Liqui-E and current Vedrop are identified separately. Ordinary tocopherol, tocopheryl acetate, topical vitamin E and unspecified excipient amounts are not assigned the same effect.
Read the interaction guide →Oral berberine with systemic oral cyclosporine. The human reports do not fully resolve the cyclosporine formulation or berberine salt, so their results are not interchangeable with every extract or product containing berberine.
Read the interaction guide →Cannabidiol used with systemic cyclosporine, with oral products the practical focus. CBD composition and dose need confirmation. Findings are not automatically applicable to topical products, THC-containing mixtures or another transplant medicine.
Read the interaction guide →Applies to oral or intravenous cyclosporine, not eye drops; replacement and monitoring depend on the treatment setting.
Read the interaction guide →Scutellaria baicalensis, Chinese skullcap, especially oral root decoctions, with systemic oral cyclosporine. Isolated baicalin, baicalein, other skullcap species and multi-herb formulas are different preparations and are not treated as direct substitutes for the root.
Read the interaction guide →Applies to oral or intravenous systemic cyclosporine, not eye drops; potassium content and other potassium-raising medicines matter.
Read the interaction guide →Citrus paradisi, grapefruit, with oral cyclosporine. The original clinical studies tested juice; the cyclosporine label also names whole grapefruit. Seed extracts, peel extracts, pomelo and other citrus are distinct exposures and are not assigned the juice studies’ percentages.
Read the interaction guide →Oral Matricaria chamomilla, also called Matricaria recutita, with systemic oral cyclosporine. The clinical signal concerns tea; exact species authentication and product strength were incomplete. Roman chamomile, topical products and concentrated extracts are not interchangeable exposures.
Read the interaction guide →